Home > Healthcare > Drug Device Combination > Drug Filled Devices > Ureteral Stents Market

Ureteral Stents Market Share

Report ID: GMI8522
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Ureteral Stents Market Share

The ureteral stents industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for ureteral stent manufacturers.

Ureteral Stents Market Companies

Some of the eminent market participants operating in the ureteral stents industry include:

Allium Medical
B.Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corporation
Coloplast
Cook Medical
Olympus Corporation
Pnn Medical A/S
Teleflex Inc.
Uromed

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ureteral stents industry was worth USD 470.6 million in revenue in 2023 and is expected to expand at 6% CAGR from 2024-2032 attributed to the increasing prevalence of urological disorders coupled with the rising need for minimally invasive procedures.

The double pigtail segment accounted for USD 177.8 million in revenue in 2023 and is estimated to record substantial growth through 2032 owing to the unique design innovation of ureteral stents, contributing to their widespread use and acceptance in urological interventions.

North America ureteral stents market generated USD 190.6 million in revenue in 2023 and is set to exhibit robust growth during 2024-2032 driven by the significant prevalence of urological disorders, including conditions, such as kidney stones, UTIs, and bladder-related issues.

Some of the major companies operating in the ureteral stents industry are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Olympus Corporation, Pnn Medical A/S, Teleflex Inc., and Uromed.